Online inquiry

IVTScrip™ mRNA-Human ACSL4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK10648MR)

This product GTTS-WK10648MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ACSL4 protein. This product can be used in Exhausted CD8+ T cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001318509.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 2182
UniProt ID O60488
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACSL4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK10648MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK9366MR IVTScrip™ mRNA-Human ABHD17A, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ABHD17A
GTTS-WK16066MR IVTScrip™ mRNA-Human AMZ2P1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AMZ2P1
GTTS-WK19316MR IVTScrip™ mRNA-Human ALG5, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ALG5
GTTS-WK7904MR IVTScrip™ mRNA-Human ACAD10, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ACAD10
GTTS-WK17842MR IVTScrip™ mRNA-Human ALPPL2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ALPPL2
GTTS-WK14253MR IVTScrip™ mRNA-Human ACSM3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ACSM3
GTTS-WK17787MR IVTScrip™ mRNA-Human ALAS1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ALAS1
GTTS-WK12151MR IVTScrip™ mRNA-Human ACSM2A, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ACSM2A
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW